Epirubicin (Ellence)
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021
Cancer. 2008 Jan 25 [Epub ahead of print] [Link] Okuno SH, Delaune R, Sloan JA, Foster NR, Maurer MJ, Aubry MC, Rowland KM Jr, Soori GS, Nikcevich DA, Kardinal CG, Northfelt DW, Adjei AA. Department of Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota. Abstract Background: The North Central Cancer Treatment Group (NCCTG) conducted a…
Read MoreChemotherapy in malignant pleural mesothelioma
Revista Portuguesa de Pneumologia. 2005 Nov;11(6 Suppl 1):14-5. [Link] Barata F, Cortesao N, Marques A, Figueiredo A. Servico Pneumologia Centro Hospitalar de Coimbra. Abstract Rational and objective: During the last few years a variety of new chemotherapy agents have been used (mostly in combination) in the treatment of malignant pleural mesothelioma (MPM). Combination therapy with…
Read MoreChemotherapy in malignant pleural mesothelioma
Revista Portuguesa de Pneumologia. 2005 Nov-Dec;11(6 Suppl 1):14-5. [Link] F B, N C, A M, A F. Servico Pneumologia Centro Hospitalar de Coimbra. Abstract Rational and objective: During the last few years a variety of new chemotherapy agents have been used (mostly in combination) in the treatment of malignant pleural mesothelioma (MPM). Combination therapy with…
Read MoreA phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma
Lung Cancer. Volume 50, Issue 1, October 2005, Pages 75-82. Available online June 13, 2005. [Link] T. Berghmansa, J.J. Lafitteb, M. Paesmansc, B. Stachd, M.C. Berchiere, P. Wackenierf, J. Lecomteg, T. Collonh, P. Mommeni, J.P. Sculiera and For the European Lung Cancer Working Party (ELCWP)1 aDepartment of Intensive Care and Thoracic Oncology, Institut Jules Bordet,…
Read More